Orthopedic Implants Market by Product Type (Reconstructive Joint Replacements, Spinal Implants, Dental Implants, Trauma, Orthobiologics, and Others), Biomaterial (Metallic, Ceramic, Polymeric, and Others), and Type (Knee, Hip, Wrist & Shoulder, Dental, Spine, Ankle, and Others): Global Opportunity Analysis and Industry Forecast, 2018 - 2025
The orthopedic implants market accounted for $45,901 million in 2017 is expected to reach $66,636 million by 2025, registering a CAGR of 4.7% from 2018 to 2025.
Orthopedic implants are medical devices that are used to replace or provide support to damaged bones or joints. These are fabricated using stainless steel and titanium alloys for strength, with plastic coating that acts as an artificial cartilage. These implants are applicable in orthopedic injuries, treatment of several types of arthritis, fractures etc. Orthopedic implants also useful in the joint replacement surgery, which is performed to remove the damaged joint and replace it with a new joint, called prosthesis. The remarkable shift from traditional invasive procedures to minimal invasive surgeries has positively impacted the market growth.
Major factors such as rise in prevalence of orthopedic injuries or diseases and rapid increase in the aging population globally drive the market. In addition, technological innovations in the orthopedic implants industry, acceptance for implantable medical devices, and improvement of healthcare infrastructure in the emerging countries further supplement the market growth. However, high cost associated with procedures involving orthopedic implants treatment and stringent government policies hamper the market growth. Furthermore, the emerging economies present lucrative opportunities to the market.
This report segments the orthopedic implants market on the basis of product type, type, material type, and region to provide a detailed assessment of the market. Based on product type, the market is divided into reconstructive joint replacements, spinal implants, dental implants, trauma, orthobiologics and others. On the basis of type, the market is segmented into knee, hip, wrist & shoulder, dental, spine, ankle, and others. Depending on material type, it is differentiated into metallic biomaterials, ceramic biomaterials, polymers biomaterials, and others. The metallic biomaterials is further segmented into stainless steel, titanium alloy, cobalt alloy, and others.
Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
KEY MARKET BENEFITS
BY Product Type
Orthopedic implants are medical devices that are used to replace or provide support to damaged bones or joints. These are fabricated using stainless steel and titanium alloys for strength, with plastic coating that acts as an artificial cartilage. These implants are applicable in orthopedic injuries, treatment of several types of arthritis, fractures etc. Orthopedic implants also useful in the joint replacement surgery, which is performed to remove the damaged joint and replace it with a new joint, called prosthesis. The remarkable shift from traditional invasive procedures to minimal invasive surgeries has positively impacted the market growth.
Major factors such as rise in prevalence of orthopedic injuries or diseases and rapid increase in the aging population globally drive the market. In addition, technological innovations in the orthopedic implants industry, acceptance for implantable medical devices, and improvement of healthcare infrastructure in the emerging countries further supplement the market growth. However, high cost associated with procedures involving orthopedic implants treatment and stringent government policies hamper the market growth. Furthermore, the emerging economies present lucrative opportunities to the market.
This report segments the orthopedic implants market on the basis of product type, type, material type, and region to provide a detailed assessment of the market. Based on product type, the market is divided into reconstructive joint replacements, spinal implants, dental implants, trauma, orthobiologics and others. On the basis of type, the market is segmented into knee, hip, wrist & shoulder, dental, spine, ankle, and others. Depending on material type, it is differentiated into metallic biomaterials, ceramic biomaterials, polymers biomaterials, and others. The metallic biomaterials is further segmented into stainless steel, titanium alloy, cobalt alloy, and others.
Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
KEY MARKET BENEFITS
- The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers a quantitative analysis from 2017 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
- A comprehensive analysis of all the regions is provided to determine the existing opportunities.
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
BY Product Type
- Reconstructive Joint Replacements
- Knee Replacement Implants
- Hip Replacement Implants
- Extremities
- Upper Extremity
- Shoulder
- Elbow
- Wrist
- Lower Extremity
- Upper
- Lower
- Spinal Implants
- Spinal Fusion Devices
- Thoracolumbar Devices
- Cervical Fixation Devices
- Interbody Fusion Devices
- Vertebral Compression Fracture (VCF) Devices
- Balloon Kyphoplasty Devices
- Vertebroplasty Devices
- Motion Preservation Devices/Non-Fusion Devices
- Dynamic Stabilization Devices
- Artificial Disc Replacement Devices
- Annulus Repair Devices
- Nuclear Disc Prostheses
- Invasive Spinal Bone Stimulators
- Dental Implants
- Root Form Dental Implants
- Plate Form Dental Implants
- Trauma
- Orthobiologics
- Demineralized Bone Matrix (DBM)
- Allograft
- Bone Morphogenetic Protein (BMP)
- Viscosupplementation Products
- Synthetic Bone Substitutes
- Others
- Others
- Metallic Biomaterials
- Stainless steel
- Titanium Alloy
- Cobalt Alloy
- Others
- Polymeric Biomaterials
- Ceramic Biomaterials
- Others
- Knee
- Hip
- Wrist & Shoulder
- Dental
- Spine
- Ankle
- Others
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Arthrex, Inc.
- Conmed Corporation
- DJO Finance LLC
- Globus Medical, Inc.
- Johnson & Johnson (DePuy Synthes)
- Medtronic plc.
- Stryker Corporation
- Smith and Nephew plc.
- Wright Medical Group N.V.
- Zimmer Biomet Holdings, Inc.
- NuVasive, Inc.
- Synthes Holding AG
- Arthrocare Corporation
- Integra Lifesciences Holdings Corporation
- Aesculap Implant Systems
- The Orthopedic Implant Company
- BioTek Instruments, Inc.
CHAPTER: 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. RESEARCH METHODOLOGY
1.2.1. Secondary research
1.2.2. Primary research
1.2.3. Analyst tools and models
CHAPTER: 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER: 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.3. Market share analysis, 2016
3.3. PORTER’S FIVE FORCES ANALYSIS
3.3.1. Bargaining power of buyers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Competitive rivalry
3.4. CLINICAL TRIALS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.1.1. Rise in incidence of orthopedic diseases coupled with growing ageing population
3.5.1.2. Technological advancements in the field of orthopedic implants
3.5.1.3. Global rise in acceptance of orthopedic implants
3.5.1.4. Improved healthcare facilities in developing countries
3.5.2. Restraints
3.5.2.1. High cost of treatment associated with orthopedic implants procedures
3.5.2.2. Stringent approval process as these are highly specialized devices
3.5.3. Opportunities
3.5.3.1. Huge market opportunities in the developing countries
CHAPTER: 4 GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. RECONSTRUCTIVE JOINT REPLACEMENTS
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Knee replacement implants
4.2.4.1. Market size and forecast
4.2.5. Hip replacement implants
4.2.5.1. Market size and forecast
4.2.6. Extremities
4.2.6.1. Market size and forecast
4.2.6.2. Upper extremity reconstruction
4.2.6.2.1. Market size and forecast
4.2.6.2.2. Shoulder reconstruction
4.2.6.2.2.1. Market size and forecast
4.2.6.2.3. Elbow reconstruction
4.2.6.2.3.1. Market size and forecast
4.2.6.2.4. Hand & wrist
4.2.6.2.4.1. Market size and forecast
4.2.6.3. Lower extremity reconstruction
4.2.6.3.1. Market size and forecast
4.2.6.3.2. Foot reconstruction
4.2.6.3.2.1. Market size and forecast
4.2.6.3.3. Ankle reconstruction
4.2.6.3.3.1. Market size and forecast
4.3. SPINAL IMPLANTS
4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Spinal fusion devices
4.3.4.1. Market size and forecast
4.3.4.2. Thoracolumbar devices
4.3.4.2.1. Market size and forecast
4.3.4.3. Cervical fixation devices
4.3.4.3.1. Market size and forecast
4.3.4.4. Interbody fusion devices
4.3.4.4.1. Market size and forecast
4.3.5. Motion preservation devices
4.3.5.1. Market size and forecast
4.3.5.2. Dynamic stabilization devices
4.3.5.2.1. Market size and forecast
4.3.5.3. Artificial discs
4.3.5.3.1. Market size and forecast
4.3.5.4. Annulus repair devices
4.3.5.4.1. Market size and forecast
4.3.5.5. Nuclear disc prostheses
4.3.5.5.1. Market size and forecast
4.3.6. Vertebral compression fracture (vcf) treatment devices
4.3.6.1. Market size and forecast
4.3.6.2. Balloon kyphoplasty devices
4.3.6.2.1. Market size and forecast
4.3.6.3. Vertebroplasty devices
4.3.6.3.1. Market size and forecast
4.3.7. Invasive spinal bone stimulators
4.3.7.1. Market size and forecast
4.4. DENTAL IMPLANTS
4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. Root form dental implants
4.4.4.1. Market size and forecast
4.4.5. Plate form dental implants
4.4.5.1. Market size and forecast
4.5. ORTHOBIOLOGICS
4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast
4.5.4. Allografts
4.5.4.1. Market size and forecast
4.5.4.2. Machined allograft
4.5.4.2.1. Market size and forecast
4.5.4.3. Demineralized bone matrix (dbm)
4.5.4.3.1. Market size and forecast
4.5.5. Bone graft substitutes
4.5.5.1. Market size and forecast
4.5.5.2. Bone morphogenic proteins (bmp)
4.5.5.2.1. Market size and forecast
4.5.5.3. Synthetic bone grafts
4.5.5.3.1. Market size and forecast
4.5.6. Cell based matrices (cbm)
4.5.6.1. Market size and forecast
4.6. TRAUMA & CRANIOMAXILLOFACIAL
4.6.1. Key market trends
4.6.2. Key growth factors and opportunities
4.6.3. Market size and forecast
4.6.4. Screw
4.6.4.1. Market size and forecast
4.6.5. Plates
4.6.5.1. Market size and forecast
4.6.6. Staples
4.6.6.1. Market size and forecast
4.6.7. Others
4.6.7.1. Market size and forecast
4.7. OTHERS
4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast
CHAPTER: 5 GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. CERAMICS BIOMATERIALS
5.2.1. Market size and forecast
5.3. METALLIC BIOMATERIALS
5.3.1. Market size and forecast
5.4. POLYMERIC BIOMATERIALS
5.4.1. Market size and forecast
5.5. NATURAL BIOMATERIALS
5.5.1. Market size and forecast
CHAPTER: 6 GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY GEOGRAPHY
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast by country
6.2.4. Market size and forecast by Product
6.2.5. Market size and forecast by Biomaterial
6.2.5.1. U.S. market size and forecast
6.2.5.2. Canada market size and forecast
6.2.5.3. Mexico market size and forecast
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast by country
6.3.4. Market size and forecast by Product
6.3.5. Market size and forecast by Biomaterial
6.3.5.1. Germany market size and forecast
6.3.5.2. France market size and forecast
6.3.5.3. UK market size and forecast
6.3.5.4. Rest of Europe market size and forecast
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast by country
6.4.4. Market size and forecast by Product
6.4.5. Market size and forecast by Biomaterial
6.4.5.1. Japan market size and forecast
6.4.5.2. China market size and forecast
6.4.5.3. India market size and forecast
6.4.5.4. Rest of Asia-Pacific market size and forecast
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast by country
6.5.4. Market size and forecast by Product
6.5.5. Market size and forecast by Biomaterial
6.5.5.1. Latin America market size and forecast
6.5.5.2. Africa market size and forecast
6.5.5.3. Middle East market size and forecast
CHAPTER: 7 COMPANY PROFILES
7.1. AESCULAP IMPLANT SYSTEMS
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Product portfolio
7.1.4. Key strategic moves and developments
7.2. B. BRAUN MELSUNGEN AG (AESCULAP AG)
7.2.1. Company overview
7.2.2. Company Snapshot
7.2.3. Operating business segments
7.2.4. Business performance
7.2.5. Key strategic moves and developments
7.3. BIOTRONIK SE & CO. KG
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Key strategic moves and developments
7.4. CONMED CORPORATION
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments
7.5. GLOBUS MEDICAL, INC.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating product categories
7.5.4. Business performance
7.5.5. Key strategic moves and developments, 2014-2016
7.6. JOHNSON & JOHNSON
7.6.1. Company overview
7.6.2. Company Snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.6.6. Key strategic moves and developments
7.7. MEDTRONIC PLC
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments
7.8. SMITH & NEPHEW PLC.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. STRYKER CORPORATION
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments
7.9.7. Operating Business Segments
7.9.8. Business performance
7.9.9. Key strategic moves and developments
7.10. ZIMMER BIOMET HOLDINGS, INC.
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating product categories
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments
1.1. REPORT DESCRIPTION
1.2. RESEARCH METHODOLOGY
1.2.1. Secondary research
1.2.2. Primary research
1.2.3. Analyst tools and models
CHAPTER: 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER: 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.3. Market share analysis, 2016
3.3. PORTER’S FIVE FORCES ANALYSIS
3.3.1. Bargaining power of buyers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Competitive rivalry
3.4. CLINICAL TRIALS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.1.1. Rise in incidence of orthopedic diseases coupled with growing ageing population
3.5.1.2. Technological advancements in the field of orthopedic implants
3.5.1.3. Global rise in acceptance of orthopedic implants
3.5.1.4. Improved healthcare facilities in developing countries
3.5.2. Restraints
3.5.2.1. High cost of treatment associated with orthopedic implants procedures
3.5.2.2. Stringent approval process as these are highly specialized devices
3.5.3. Opportunities
3.5.3.1. Huge market opportunities in the developing countries
CHAPTER: 4 GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. RECONSTRUCTIVE JOINT REPLACEMENTS
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Knee replacement implants
4.2.4.1. Market size and forecast
4.2.5. Hip replacement implants
4.2.5.1. Market size and forecast
4.2.6. Extremities
4.2.6.1. Market size and forecast
4.2.6.2. Upper extremity reconstruction
4.2.6.2.1. Market size and forecast
4.2.6.2.2. Shoulder reconstruction
4.2.6.2.2.1. Market size and forecast
4.2.6.2.3. Elbow reconstruction
4.2.6.2.3.1. Market size and forecast
4.2.6.2.4. Hand & wrist
4.2.6.2.4.1. Market size and forecast
4.2.6.3. Lower extremity reconstruction
4.2.6.3.1. Market size and forecast
4.2.6.3.2. Foot reconstruction
4.2.6.3.2.1. Market size and forecast
4.2.6.3.3. Ankle reconstruction
4.2.6.3.3.1. Market size and forecast
4.3. SPINAL IMPLANTS
4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Spinal fusion devices
4.3.4.1. Market size and forecast
4.3.4.2. Thoracolumbar devices
4.3.4.2.1. Market size and forecast
4.3.4.3. Cervical fixation devices
4.3.4.3.1. Market size and forecast
4.3.4.4. Interbody fusion devices
4.3.4.4.1. Market size and forecast
4.3.5. Motion preservation devices
4.3.5.1. Market size and forecast
4.3.5.2. Dynamic stabilization devices
4.3.5.2.1. Market size and forecast
4.3.5.3. Artificial discs
4.3.5.3.1. Market size and forecast
4.3.5.4. Annulus repair devices
4.3.5.4.1. Market size and forecast
4.3.5.5. Nuclear disc prostheses
4.3.5.5.1. Market size and forecast
4.3.6. Vertebral compression fracture (vcf) treatment devices
4.3.6.1. Market size and forecast
4.3.6.2. Balloon kyphoplasty devices
4.3.6.2.1. Market size and forecast
4.3.6.3. Vertebroplasty devices
4.3.6.3.1. Market size and forecast
4.3.7. Invasive spinal bone stimulators
4.3.7.1. Market size and forecast
4.4. DENTAL IMPLANTS
4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. Root form dental implants
4.4.4.1. Market size and forecast
4.4.5. Plate form dental implants
4.4.5.1. Market size and forecast
4.5. ORTHOBIOLOGICS
4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast
4.5.4. Allografts
4.5.4.1. Market size and forecast
4.5.4.2. Machined allograft
4.5.4.2.1. Market size and forecast
4.5.4.3. Demineralized bone matrix (dbm)
4.5.4.3.1. Market size and forecast
4.5.5. Bone graft substitutes
4.5.5.1. Market size and forecast
4.5.5.2. Bone morphogenic proteins (bmp)
4.5.5.2.1. Market size and forecast
4.5.5.3. Synthetic bone grafts
4.5.5.3.1. Market size and forecast
4.5.6. Cell based matrices (cbm)
4.5.6.1. Market size and forecast
4.6. TRAUMA & CRANIOMAXILLOFACIAL
4.6.1. Key market trends
4.6.2. Key growth factors and opportunities
4.6.3. Market size and forecast
4.6.4. Screw
4.6.4.1. Market size and forecast
4.6.5. Plates
4.6.5.1. Market size and forecast
4.6.6. Staples
4.6.6.1. Market size and forecast
4.6.7. Others
4.6.7.1. Market size and forecast
4.7. OTHERS
4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast
CHAPTER: 5 GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. CERAMICS BIOMATERIALS
5.2.1. Market size and forecast
5.3. METALLIC BIOMATERIALS
5.3.1. Market size and forecast
5.4. POLYMERIC BIOMATERIALS
5.4.1. Market size and forecast
5.5. NATURAL BIOMATERIALS
5.5.1. Market size and forecast
CHAPTER: 6 GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY GEOGRAPHY
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast by country
6.2.4. Market size and forecast by Product
6.2.5. Market size and forecast by Biomaterial
6.2.5.1. U.S. market size and forecast
6.2.5.2. Canada market size and forecast
6.2.5.3. Mexico market size and forecast
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast by country
6.3.4. Market size and forecast by Product
6.3.5. Market size and forecast by Biomaterial
6.3.5.1. Germany market size and forecast
6.3.5.2. France market size and forecast
6.3.5.3. UK market size and forecast
6.3.5.4. Rest of Europe market size and forecast
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast by country
6.4.4. Market size and forecast by Product
6.4.5. Market size and forecast by Biomaterial
6.4.5.1. Japan market size and forecast
6.4.5.2. China market size and forecast
6.4.5.3. India market size and forecast
6.4.5.4. Rest of Asia-Pacific market size and forecast
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast by country
6.5.4. Market size and forecast by Product
6.5.5. Market size and forecast by Biomaterial
6.5.5.1. Latin America market size and forecast
6.5.5.2. Africa market size and forecast
6.5.5.3. Middle East market size and forecast
CHAPTER: 7 COMPANY PROFILES
7.1. AESCULAP IMPLANT SYSTEMS
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Product portfolio
7.1.4. Key strategic moves and developments
7.2. B. BRAUN MELSUNGEN AG (AESCULAP AG)
7.2.1. Company overview
7.2.2. Company Snapshot
7.2.3. Operating business segments
7.2.4. Business performance
7.2.5. Key strategic moves and developments
7.3. BIOTRONIK SE & CO. KG
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Key strategic moves and developments
7.4. CONMED CORPORATION
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments
7.5. GLOBUS MEDICAL, INC.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating product categories
7.5.4. Business performance
7.5.5. Key strategic moves and developments, 2014-2016
7.6. JOHNSON & JOHNSON
7.6.1. Company overview
7.6.2. Company Snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.6.6. Key strategic moves and developments
7.7. MEDTRONIC PLC
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments
7.8. SMITH & NEPHEW PLC.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. STRYKER CORPORATION
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments
7.9.7. Operating Business Segments
7.9.8. Business performance
7.9.9. Key strategic moves and developments
7.10. ZIMMER BIOMET HOLDINGS, INC.
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating product categories
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments
LIST OF TABLES
TABLE 1. GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 2. GLOBAL RECONSTRUCTIVE JOINT REPLACEMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 3. KNEE REPLACEMENT IMPLANTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 4. HIP REPLACEMENT IMPLANTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 5. EXTREMITIES IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 6. GLOBAL UPPER EXTREMITIES IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 7. SHOULDER RECONSTRUCTION MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 8. ELBOW RECONSTRUCTION MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 9. HAND & WRIST RECONSTRUCTION MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 10. GLOBAL LOWER EXTREMITIES IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 11. FOOT RECONSTRUCTION MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 12. ANKLE RECONSTRUCTION MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 13. PRODUCT ANALYSIS: SPINAL IMPLANTS
TABLE 14. GLOBAL SPINAL IMPALNTS ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 15. GLOBAL SPINAL FUSION DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 16. THORACOLUMBAR DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 17. CERVICAL FIXATION DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 18. INTERBODY FUSION DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 19. GLOBAL MOTION PRESERVATION DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 20. DYNAMIC STABILIZATION DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 21. ARTIFICIAL DISCS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 22. ANNULUS REPAIR DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 23. NUCLEAR DISC PROSTHESES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 24. GLOBAL VERTEBRAL COMPRESSION FRACTURE MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 25. BALLOON KYPHOPLASTY DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 26. VERTEBROPLASTY DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 27. INVASIVE SPINAL BONE STIMULATORS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 28. GLOBAL DENTAL IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 29. ROOT-FORM DENTAL IMPLANT MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 30. PLATE-FORM DENTAL IMPLANT MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 31. GLOBAL ORTHOBIOLOGICS IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 32. GLOBAL ALLOGRAFT IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 33. MACHINED ALLOGRAFTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 34. DEMINERALIZED BONE MATRIX MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 35. GLOBAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 36. BONE MORPHOGENETIC PROTEIN MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 37. SYNTHETIC BONE GRAFTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 38. CELL BASED MATRICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 39. GLOBAL TRAUMA AND CRANIOMAXILLOFACIAL MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 40. DIFFERENT TYPES OF BONE SCREWS AND THEIR APPLICATION
TABLE 41. TRAUMA AND CRANIOMAXILLOFACIAL MARKET FOR SCREW, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 42. TRAUMA AND CRANIOMAXILLOFACIAL MARKET FOR PLATES, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 43. TRAUMA AND CRANIOMAXILLOFACIAL MARKET FOR STAPLES, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 44. OTHER TRAUMA AND CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 45. OTHER ORTHOPEDIC IMPLANTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 46. GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2016-2023 ($MILLION)
TABLE 47. CERAMICS BIOMATERIALS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 48. METALLIC BIOMATERIALS AND THEIR APPLICATIONS
TABLE 49. METALLIC BIOMATERIALS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 50. POLYMERIC BIOMATERIALS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 51. NATURAL BIOMATERIALS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 52. ORTHOPEDIC IMPLANTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 53. NORTH AMERICA ORTHOPEDIC IMPLANT MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 54. NORTH AMERICA ORTHOPEDIC IMPLANT MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 55. NORTH AMERICA ORTHOPEDIC IMPLANT MARKET, BY BIOMATERIAL, 2016-2023 ($MILLION)
TABLE 56. RHEUMATOID ARTHRITIS CASES IN THE UK EACH YEAR
TABLE 57. EUROPE ORTHOPEDIC IMPLANT MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 58. EUROPE ORTHOPEDIC IMPLANT MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 59. EUROPE ORTHOPEDIC IMPLANT MARKET, BY BIOMATERIAL, 2016-2023 ($MILLION)
TABLE 60. ASIA-PACIFIC ORTHOPEDIC IMPLANT MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 61. ASIA-PACIFIC ORTHOPEDIC IMPLANT MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 62. ASIA-PACIFIC ORTHOPEDIC IMPLANT MARKET, BY BIOMATERIAL, 2016-2023 ($MILLION)
TABLE 63. LAMEA ORTHOPEDIC IMPLANT MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 64. LAMEA ORTHOPEDIC IMPLANT MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 65. LAMEA ORTHOPEDIC IMPLANT MARKET, BY BIOMATERIAL, 2016-2023 ($MILLION)
TABLE 66. AESCULAP: COMPANY SNAPSHOT
TABLE 67. AESCULAP: PRODUCT PORTFOLIO
TABLE 68. B. BRAUN: COMPANY SNAPSHOT
TABLE 69. B. BRAUN: OPERATING SEGMENTS
TABLE 70. BIOTRONIK: COMPANY SNAPSHOT
TABLE 71. BIOTRONIK: OPERATING SEGMENTS
TABLE 72. BIOTRONIK: PRODUCT PORTFOLIO
TABLE 73. CONMED: COMPANY SNAPSHOT
TABLE 74. CONMED: OPERATING SEGMENTS
TABLE 75. CONMED: PRODUCT PORTFOLIO
TABLE 76. GLOBUS MEDICAL: COMPANY SNAPSHOT
TABLE 77. GLOBUS MEDICAL: PRODUCT CATEGORIES
TABLE 78. J&J: COMPANY SNAPSHOT
TABLE 79. J&J: OPERATING SEGMENTS
TABLE 80. J&J: PRODUCT PORTFOLIO
TABLE 81. MEDTRONIC: COMPANY SNAPSHOT
TABLE 82. MEDTRONIC: OPERATING SEGMENTS
TABLE 83. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 84. SMITH & NEPHEW: COMPANY SNAPSHOT
TABLE 85. SMITH & NEPHEW: PRODUCT PORTFOLIO
TABLE 86. STRYKER: COMPANY SNAPSHOT
TABLE 87. STRYKER: OPERATING SEGMENTS
TABLE 88. STRYKER: PRODUCT PORTFOLIO
TABLE 89. WRIGHT MEDICAL: COMPANY SNAPSHOT
TABLE 90. WRIGHT MEDICAL: OPERATING SEGMENTS
TABLE 91. ZIMMER BIOMET: COMPANY SNAPSHOT
TABLE 92. ZIMMER BIOMET: PRODUCT CATEGORIES
TABLE 93. ZIMMER BIOMET: PRODUCT PORTFOLIO
TABLE 1. GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 2. GLOBAL RECONSTRUCTIVE JOINT REPLACEMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 3. KNEE REPLACEMENT IMPLANTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 4. HIP REPLACEMENT IMPLANTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 5. EXTREMITIES IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 6. GLOBAL UPPER EXTREMITIES IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 7. SHOULDER RECONSTRUCTION MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 8. ELBOW RECONSTRUCTION MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 9. HAND & WRIST RECONSTRUCTION MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 10. GLOBAL LOWER EXTREMITIES IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 11. FOOT RECONSTRUCTION MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 12. ANKLE RECONSTRUCTION MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 13. PRODUCT ANALYSIS: SPINAL IMPLANTS
TABLE 14. GLOBAL SPINAL IMPALNTS ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 15. GLOBAL SPINAL FUSION DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 16. THORACOLUMBAR DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 17. CERVICAL FIXATION DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 18. INTERBODY FUSION DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 19. GLOBAL MOTION PRESERVATION DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 20. DYNAMIC STABILIZATION DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 21. ARTIFICIAL DISCS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 22. ANNULUS REPAIR DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 23. NUCLEAR DISC PROSTHESES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 24. GLOBAL VERTEBRAL COMPRESSION FRACTURE MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 25. BALLOON KYPHOPLASTY DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 26. VERTEBROPLASTY DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 27. INVASIVE SPINAL BONE STIMULATORS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 28. GLOBAL DENTAL IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 29. ROOT-FORM DENTAL IMPLANT MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 30. PLATE-FORM DENTAL IMPLANT MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 31. GLOBAL ORTHOBIOLOGICS IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 32. GLOBAL ALLOGRAFT IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 33. MACHINED ALLOGRAFTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 34. DEMINERALIZED BONE MATRIX MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 35. GLOBAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 36. BONE MORPHOGENETIC PROTEIN MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 37. SYNTHETIC BONE GRAFTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 38. CELL BASED MATRICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 39. GLOBAL TRAUMA AND CRANIOMAXILLOFACIAL MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 40. DIFFERENT TYPES OF BONE SCREWS AND THEIR APPLICATION
TABLE 41. TRAUMA AND CRANIOMAXILLOFACIAL MARKET FOR SCREW, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 42. TRAUMA AND CRANIOMAXILLOFACIAL MARKET FOR PLATES, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 43. TRAUMA AND CRANIOMAXILLOFACIAL MARKET FOR STAPLES, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 44. OTHER TRAUMA AND CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 45. OTHER ORTHOPEDIC IMPLANTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 46. GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2016-2023 ($MILLION)
TABLE 47. CERAMICS BIOMATERIALS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 48. METALLIC BIOMATERIALS AND THEIR APPLICATIONS
TABLE 49. METALLIC BIOMATERIALS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 50. POLYMERIC BIOMATERIALS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 51. NATURAL BIOMATERIALS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 52. ORTHOPEDIC IMPLANTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 53. NORTH AMERICA ORTHOPEDIC IMPLANT MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 54. NORTH AMERICA ORTHOPEDIC IMPLANT MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 55. NORTH AMERICA ORTHOPEDIC IMPLANT MARKET, BY BIOMATERIAL, 2016-2023 ($MILLION)
TABLE 56. RHEUMATOID ARTHRITIS CASES IN THE UK EACH YEAR
TABLE 57. EUROPE ORTHOPEDIC IMPLANT MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 58. EUROPE ORTHOPEDIC IMPLANT MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 59. EUROPE ORTHOPEDIC IMPLANT MARKET, BY BIOMATERIAL, 2016-2023 ($MILLION)
TABLE 60. ASIA-PACIFIC ORTHOPEDIC IMPLANT MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 61. ASIA-PACIFIC ORTHOPEDIC IMPLANT MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 62. ASIA-PACIFIC ORTHOPEDIC IMPLANT MARKET, BY BIOMATERIAL, 2016-2023 ($MILLION)
TABLE 63. LAMEA ORTHOPEDIC IMPLANT MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 64. LAMEA ORTHOPEDIC IMPLANT MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 65. LAMEA ORTHOPEDIC IMPLANT MARKET, BY BIOMATERIAL, 2016-2023 ($MILLION)
TABLE 66. AESCULAP: COMPANY SNAPSHOT
TABLE 67. AESCULAP: PRODUCT PORTFOLIO
TABLE 68. B. BRAUN: COMPANY SNAPSHOT
TABLE 69. B. BRAUN: OPERATING SEGMENTS
TABLE 70. BIOTRONIK: COMPANY SNAPSHOT
TABLE 71. BIOTRONIK: OPERATING SEGMENTS
TABLE 72. BIOTRONIK: PRODUCT PORTFOLIO
TABLE 73. CONMED: COMPANY SNAPSHOT
TABLE 74. CONMED: OPERATING SEGMENTS
TABLE 75. CONMED: PRODUCT PORTFOLIO
TABLE 76. GLOBUS MEDICAL: COMPANY SNAPSHOT
TABLE 77. GLOBUS MEDICAL: PRODUCT CATEGORIES
TABLE 78. J&J: COMPANY SNAPSHOT
TABLE 79. J&J: OPERATING SEGMENTS
TABLE 80. J&J: PRODUCT PORTFOLIO
TABLE 81. MEDTRONIC: COMPANY SNAPSHOT
TABLE 82. MEDTRONIC: OPERATING SEGMENTS
TABLE 83. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 84. SMITH & NEPHEW: COMPANY SNAPSHOT
TABLE 85. SMITH & NEPHEW: PRODUCT PORTFOLIO
TABLE 86. STRYKER: COMPANY SNAPSHOT
TABLE 87. STRYKER: OPERATING SEGMENTS
TABLE 88. STRYKER: PRODUCT PORTFOLIO
TABLE 89. WRIGHT MEDICAL: COMPANY SNAPSHOT
TABLE 90. WRIGHT MEDICAL: OPERATING SEGMENTS
TABLE 91. ZIMMER BIOMET: COMPANY SNAPSHOT
TABLE 92. ZIMMER BIOMET: PRODUCT CATEGORIES
TABLE 93. ZIMMER BIOMET: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 1. GLOBAL SNAPSHOT OF ORTHOPEDIC IMPLANTS MARKET, 2016-2023
FIGURE 2. SNAPSHOT OF ORTHOPEDIC IMPLANTS MARKET, BY GEOGRAPHY, 2016-2023
FIGURE 3. GLOBAL ORTHOPEDIC IMPLANTS MARKET SEGMENTATION
FIGURE 4. TOP INVESTMENT POCKETS IN GLOBAL ORTHOPEDIC IMPLANTS MARKET
FIGURE 5. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 2014-2016
FIGURE 6. TOTAL NUMBER OF STRATEGIES
FIGURE 7. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 8. MARKET SHARE ANALYSIS: ORTHOPEDIC IMPLANTS MARKET, 2016
FIGURE 9. BARGAINING POWER OF BUYERS, 2016
FIGURE 10. BARGAINING POWER OF SUPPLIERS, 2016
FIGURE 11. THREAT OF SUBSTITUTES, 2016
FIGURE 12. THREAT OF NEW ENTRANTS, 2016
FIGURE 13. COMPETITIVE RIVALRY, 2016
FIGURE 14. CLINICAL TRIALS FOR ORTHOPEDIC IMPLANTS (%)
FIGURE 15. ORTHOPEDIC IMPLANTS: MARKET DYNAMICS
FIGURE 16. GLOBAL ORTHOPEDIC IMPLANT MARKET: IMPACT ANALYSIS
FIGURE 17. GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY TYPE
FIGURE 18. U.S. ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 19. CANADA ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 20. MEXICO ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 21. GERMANY ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 22. FRANCE ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 23. UK ORTHOPEDIC IMPLANTS DMARKET, 2016-2023 ($MILLION)
FIGURE 24. REST OF EUROPE ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 25. JAPAN ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 26. CHINA ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 27. INDIA ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 28. REST OF ASIA-PACIFIC ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 29. LATIN AMERICA ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 30. SOUTH AFRICA ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 31. MIDDLE EAST ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 32. B. BRAUN: NET SALES, 2014-2016 ($MILLION)
FIGURE 33. B. BRAUN: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 34. B. BRAUN: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 35. CONMED: NET SALES, 2014-2016 ($MILLION)
FIGURE 36. CONMED: REVENUE SHARE BY PRODUCT, 2016 (%)
FIGURE 37. CONMED: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 38. GLOBUS MEDICAL: REVENUE, 2014-2016 ($MILLION)
FIGURE 39. GLOBUS MEDICAL: REVENUE BY REGION, 2016 (%)
FIGURE 40. GLOBUS MEDICAL: REVENUE BY PRODUCT, 2016 (%)
FIGURE 41. J&J: NET SALES, 2014-2016 ($MILLION)
FIGURE 42. J&J: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 43. J&J: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 44. MEDTRONIC: NET SALES, 2014-2016 ($MILLION)
FIGURE 45. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 46. MEDTRONIC: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 47. SMITH & NEPHEW: NET SALES, 2014-2016 ($MILLION)
FIGURE 48. SMITH & NEPHEW: REVENUE SHARE BY PRODUCT, 2016 (%)
FIGURE 49. SMITH & NEPHEW: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 50. STRYKER: NET SALES, 2014-2016 ($MILLION)
FIGURE 51. STRYKER: REVENUE SHARE BY PRODUCT, 2016 (%)
FIGURE 52. STRYKER: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 53. WRIGHT MEDICAL: NET SALES, 2014-2016 ($MILLION)
FIGURE 54. WRIGHT MEDICAL: REVENUE SHARE, BY PRODUCT, 2016 (%)
FIGURE 55. WRIGHT MEDICAL: REVENUE SHARE, BY GEOGRAPHY, 2016 (%)
FIGURE 56. ZIMMER BIOMET: NET SALES, 2014-2016 ($MILLION)
FIGURE 57. ZIMMER BIOMET: REVENUE SHARE BY SEGMENTS, 2016 (%)
FIGURE 58. ZIMMER BIOMET: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 1. GLOBAL SNAPSHOT OF ORTHOPEDIC IMPLANTS MARKET, 2016-2023
FIGURE 2. SNAPSHOT OF ORTHOPEDIC IMPLANTS MARKET, BY GEOGRAPHY, 2016-2023
FIGURE 3. GLOBAL ORTHOPEDIC IMPLANTS MARKET SEGMENTATION
FIGURE 4. TOP INVESTMENT POCKETS IN GLOBAL ORTHOPEDIC IMPLANTS MARKET
FIGURE 5. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 2014-2016
FIGURE 6. TOTAL NUMBER OF STRATEGIES
FIGURE 7. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 8. MARKET SHARE ANALYSIS: ORTHOPEDIC IMPLANTS MARKET, 2016
FIGURE 9. BARGAINING POWER OF BUYERS, 2016
FIGURE 10. BARGAINING POWER OF SUPPLIERS, 2016
FIGURE 11. THREAT OF SUBSTITUTES, 2016
FIGURE 12. THREAT OF NEW ENTRANTS, 2016
FIGURE 13. COMPETITIVE RIVALRY, 2016
FIGURE 14. CLINICAL TRIALS FOR ORTHOPEDIC IMPLANTS (%)
FIGURE 15. ORTHOPEDIC IMPLANTS: MARKET DYNAMICS
FIGURE 16. GLOBAL ORTHOPEDIC IMPLANT MARKET: IMPACT ANALYSIS
FIGURE 17. GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY TYPE
FIGURE 18. U.S. ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 19. CANADA ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 20. MEXICO ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 21. GERMANY ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 22. FRANCE ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 23. UK ORTHOPEDIC IMPLANTS DMARKET, 2016-2023 ($MILLION)
FIGURE 24. REST OF EUROPE ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 25. JAPAN ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 26. CHINA ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 27. INDIA ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 28. REST OF ASIA-PACIFIC ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 29. LATIN AMERICA ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 30. SOUTH AFRICA ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 31. MIDDLE EAST ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 32. B. BRAUN: NET SALES, 2014-2016 ($MILLION)
FIGURE 33. B. BRAUN: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 34. B. BRAUN: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 35. CONMED: NET SALES, 2014-2016 ($MILLION)
FIGURE 36. CONMED: REVENUE SHARE BY PRODUCT, 2016 (%)
FIGURE 37. CONMED: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 38. GLOBUS MEDICAL: REVENUE, 2014-2016 ($MILLION)
FIGURE 39. GLOBUS MEDICAL: REVENUE BY REGION, 2016 (%)
FIGURE 40. GLOBUS MEDICAL: REVENUE BY PRODUCT, 2016 (%)
FIGURE 41. J&J: NET SALES, 2014-2016 ($MILLION)
FIGURE 42. J&J: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 43. J&J: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 44. MEDTRONIC: NET SALES, 2014-2016 ($MILLION)
FIGURE 45. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 46. MEDTRONIC: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 47. SMITH & NEPHEW: NET SALES, 2014-2016 ($MILLION)
FIGURE 48. SMITH & NEPHEW: REVENUE SHARE BY PRODUCT, 2016 (%)
FIGURE 49. SMITH & NEPHEW: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 50. STRYKER: NET SALES, 2014-2016 ($MILLION)
FIGURE 51. STRYKER: REVENUE SHARE BY PRODUCT, 2016 (%)
FIGURE 52. STRYKER: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 53. WRIGHT MEDICAL: NET SALES, 2014-2016 ($MILLION)
FIGURE 54. WRIGHT MEDICAL: REVENUE SHARE, BY PRODUCT, 2016 (%)
FIGURE 55. WRIGHT MEDICAL: REVENUE SHARE, BY GEOGRAPHY, 2016 (%)
FIGURE 56. ZIMMER BIOMET: NET SALES, 2014-2016 ($MILLION)
FIGURE 57. ZIMMER BIOMET: REVENUE SHARE BY SEGMENTS, 2016 (%)
FIGURE 58. ZIMMER BIOMET: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
